Surgery Partners Ownership
| SGRY Stock | USD 25.05 0.39 1.53% |
Shares in Circulation | First Issued 2014-09-30 | Previous Quarter 126.1 M | Current Value 126.2 M | Avarage Shares Outstanding 68.2 M | Quarterly Volatility 30.3 M |
Surgery |
Surgery Stock Ownership Analysis
About 98.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.71. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgery Partners has Price/Earnings To Growth (PEG) ratio of 1.66. The entity recorded a loss per share of 0.47. The firm had not issued any dividends in recent years. Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee. Surgery Partners operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 8300 people. To find out more about Surgery Partners contact the company at 615 234 5900 or learn more at https://www.surgerypartners.com.Surgery Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Surgery Partners is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Surgery Partners backward and forwards among themselves. Surgery Partners' institutional investor refers to the entity that pools money to purchase Surgery Partners' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-12-31 | 1.9 M | Point72 Asset Management, L.p. | 2024-12-31 | 1.7 M | American Century Companies Inc | 2024-12-31 | 1.4 M | Goldman Sachs Group Inc | 2024-12-31 | 1.3 M | E Ohman J:or Asset Management Ab | 2024-12-31 | 1.2 M | Victory Capital Management Inc. | 2024-12-31 | 1.2 M | Hein Park Capital Management Lp | 2024-12-31 | 1.1 M | Silvercrest Asset Management Group Llc | 2024-12-31 | 998.5 K | Ubs Group Ag | 2024-12-31 | 990.2 K | Bain Capital Investors Llc | 2024-12-31 | 49.9 M | Fmr Inc | 2024-12-31 | 16.3 M |
Surgery Partners Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Surgery Partners insiders, such as employees or executives, is commonly permitted as long as it does not rely on Surgery Partners' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Surgery Partners insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Surgery Partners Outstanding Bonds
Surgery Partners issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Surgery Partners uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Surgery bonds can be classified according to their maturity, which is the date when Surgery Partners has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Surgery Partners Corporate Filings
| 12th of February 2025 Other Reports | ViewVerify | |
F4 | 4th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 30th of January 2025 Other Reports | ViewVerify | |
| 28th of January 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.